Pere Rehues

Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

Ana González-Lleó, Rosa M. Sánchez-Hernández, Núria Plana et al. · Cardiovascular Diabetology · 2024 · 20 citations · Full text

Medicine, Endocrinology, Pharmacology +13

PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

Pere Rehues, Josefa Girona, Montse Guardiola et al. · International Journal of Molecular Sciences · 2023 · 15 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects

M. Mar Rodríguez, Pere Rehues, Víctor Iranzo et al. · Journal of Proteomics · 2021 · 14 citations · Full text

Life Sciences, Biochemistry, Cardiovascular Genetics +16

NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es study

Enrique Ozcariz, Montse Guardiola, Núria Amigó et al. · Diabetes Research and Clinical Practice · 2023 · 11 citations

Life Sciences, Biochemistry, Physiology +15

Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men

Pere Rehues, M. Mar Rodríguez, Judith Alvarez-Borillo et al. · Biomolecules · 2021 · 10 citations · Full text

Life Sciences, Biochemistry, Immunology +15